Cytokinetics Inc (CYTK)

Precedente Chiudi:

$65.34

Aprire:

$64.95

Volume 24 ore:

251.45K

Capitalizzazione di mercato:

$6.83B

Reddito:

$7.53M

Utile/perdita netta:

$-526.24M

Rapporto P/E:

-11.60

EPS:

-5.52

Flusso di cassa netto:

$-415.75M

1 W Prestazione:

-3.40%

1M Prestazione:

-8.67%

6M Prestazione:

+101.75%

1 anno Prestazione:

+71.21%

Intervallo 1D:

$63.92

$65.00

Portata 52W:

$25.98

$110.25

Cytokinetics Inc Stock (CYTK) Company Profile

Nome

Cytokinetics Inc

Settore

Healthcare (1203)

Industria

Biotechnology (688)

Telefono

650-624-3000

Indirizzo

280 East Grand Avenue, South San Francisco, CA

Dipendente

137

Cinguettio

@Cytokinetics

Prossima data di guadagno

2024-05-15

Ultimi documenti SEC

CYTK's Discussions on Twitter

Cytokinetics Inc Stock (CYTK) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-01-24	Downgrade	UBS	Buy → Neutral
2024-01-05	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-11-09	Iniziato	Goldman	Buy
2023-11-07	Iniziato	B. Riley Securities	Buy
2023-08-15	Iniziato	SVB Securities	Outperform
2023-02-17	Iniziato	BofA Securities	Neutral
2022-12-23	Reiterato	Needham	Buy
2022-12-20	Iniziato	Truist	Buy
2022-10-11	Iniziato	UBS	Buy
2022-01-28	Iniziato	Goldman	Buy
2021-12-22	Iniziato	Oppenheimer	Outperform
2021-12-10	Iniziato	JP Morgan	Overweight
2021-10-07	Iniziato	Jefferies	Buy
2021-03-12	Iniziato	Wolfe Research	Outperform
2021-02-18	Iniziato	Barclays	Overweight
2021-01-20	Reiterato	H.C. Wainwright	Buy
2020-10-29	Iniziato	Goldman	Neutral
2020-07-10	Iniziato	Raymond James	Strong Buy
2020-05-05	Iniziato	Mizuho	Buy
2020-04-09	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2018-09-21	Iniziato	Cantor Fitzgerald	Overweight
2018-09-10	Ripresa	Morgan Stanley	Equal-Weight
2017-11-22	Reiterato	Morgan Stanley	Overweight
2017-11-22	Downgrade	Needham	Strong Buy → Buy
2017-11-21	Reiterato	H.C. Wainwright	Buy
2017-07-31	Iniziato	Morgan Stanley	Overweight
2017-03-08	Iniziato	Rodman & Renshaw	Buy
2017-02-06	Aggiornamento	Needham	Buy → Strong Buy
2016-12-16	Iniziato	Cantor Fitzgerald	Overweight
2016-07-28	Reiterato	Needham	Buy
2015-11-10	Reiterato	FBR Capital	Outperform
2015-11-09	Reiterato	ROTH Capital	Buy
2015-07-24	Reiterato	MLV & Co	Buy
2014-12-31	Reiterato	ROTH Capital	Buy
2014-11-04	Aggiornamento	MLV & Co	Hold → Buy
2014-04-28	Reiterato	Needham	Buy

Mostra tutto

Cytokinetics Inc Borsa (CYTK) Ultime notizie

Cytokinetics to Announce First Quarter Results on May 8, 2024

GlobeNewswire Inc.

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

GlobeNewswire Inc.

Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session

GlobeNewswire Inc.

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire Inc.

Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session

GlobeNewswire Inc.

Cytokinetics Inc Azioni (CYTK) Dati Finanziari

Cytokinetics Inc (CYTK) Reddito 2024

Cytokinetics Inc (CYTK) Reddito netto 2024

Cytokinetics Inc (CYTK) Flusso di cassa 2024

Cytokinetics Inc (CYTK) Utile per azione 2024

Cytokinetics Inc Azioni (CYTK) insider trading